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ABSTRACT
Background Mild therapeutic hypothermia is argued being beneficial for outcome after cardiac arrest.
Materials and methods Retrospective analysis of Circulation Improving Resuscitation Care (CIRC) trial data to
assess if therapeutic cooling to 33  1 °C core temperature had an association with survival. Of 4231 adult, out-
of-hospital cardiac arrests of presumed cardiac origin initially enrolled, eligibility criteria for therapeutic
hypothermia were met by 1812. Logistic regression was undertaken in a stepwise fashion to account for the
impact on outcome of each significant difference and for the variable of interest between the groups.
Results Out-of- and in-hospital cooled were 263 (15%), only after admission cooled were 230 (13%) and not
cooled were 357 (20%) patients. The group cooled out of- and in hospital had 98 (37%) survivors as compared to
the groups cooled in hospital only [80 (35%)] and of those not cooled [68 (19%)]. After adjusting for known
covariates (sex, age, witnessed cardiac arrest, no- and low-flow time, shockable initial rhythm, random alloca-
tion, bystander cardiopulmonary resuscitation and percutaneous coronary intervention), the odds ratio for sur-
vival comparing no cooling to out-of- plus in-hospital cooling was 053 [95% confidence interval (CI): 046–061,
P < 0001], and comparing to in-hospital cooling only was 067 (95% CI: 050–089, P = 0006).
Conclusion Mild therapeutic hypothermia initiated out of hospital and/or in hospital was associated with
improved survival within this secondary analysis of the CIRC cohort compared to no therapeutic hypothermia.
Keywords Cardiopulmonary resuscitation, heart arrest, resuscitation, survival, trials.
Eur J Clin Invest 2017; 47 (6): 439–446
Introduction
Mild therapeutic hypothermia is considered beneficial based on
meta-analyses from randomised controlled trials comparing
therapeutic hypothermia to no cooling [1]. This notion was
recently challenged based on the results from a pragmatic
randomised trial that reported a long time to approaching tar-
get temperature in the moderate hypothermia group, and no
significant difference in survival or neurologic status over time
between the mild vs. moderate hypothermia group [2]. The
optimal timing for induction of hypothermia is uncertain [3].
The Circulation Improving Resuscitation Care (CIRC) trial
determined equivalence between automated load distributing
band (LDB) cardiopulmonary resuscitation (CPR) integrated
1Harald Herkner planned and conducted the statistical analyses.
2Reinhard Malzer, MD deceased 13 April 2013 due to an avalanche in
the Alps.
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with manual CPR (iLDB-CPR) to high quality manual CPR (M-
CPR) in survival of out-of-hospital cardiac arrest patients [4].
This large, study cohort allowed for a nonrandomised obser-
vational assessments of the effects of mild therapeutic
hypothermia on clinically relevant outcomes.
The aim of this study was to explore an association between
mild therapeutic hypothermia with particular attention to out-
of-hospital and/or in-hospital initiation and maintenance of
therapeutic hypothermia on outcome within the ‘chain of sur-
vival’ [5] in initial survivors of out-of-hospital cardiac arrest
from patients enrolled into the CIRC trial [4].
Materials and methods
The CIRC trial was a randomised, controlled ‘group sequential’
trial of adult out-of-hospital cardiac arrest patients of presumed
cardiac origin conducted under exception from informed con-
sent for emergency research and approved by the supervising
Institutional Review Boards (three US sites) or Ethics commit-
tees (two European sites) at each site [6]. Reporting of the study
conforms to STROBE statement [7]. Sites represented a variety
of emergency medical service system types and covered pop-
ulations that ranged from 135 141 to 2 144 491 with response
areas between 68 and 888 square miles. The CIRC trial methods
paper with the rational and design of the trial in addition to the
statistical analysis plan have been published previously [6].
Study design
Cohort study from patients initially enrolled into the CIRC trial
to investigate the effect of therapeutic hypothermia on survival.
Selection of subjects
We analysed all patients, who showed any return of sponta-
neous circulation (≥ 60 s) and who were not waking up – thus
having been potentially eligible for therapeutic hypothermia
[8]. Patients were excluded if they were presumed to be preg-
nant, had a Do Not Resuscitate order, and were a prisoner or
were a ward of the state.
Therapeutic hypothermia
Therapeutic hypothermia was the exposure of interest and
categorised according to the initiation of therapeutic
hypothermia out of plus in hospital, in hospital (either emer-
gency department and/or intensive care unit) or no cooling.
Part of CIRC trial protocol were resuscitation guidelines in
place at the time of the study, which directed that all patients
receive protection of their airway and artificial ventilation,
hemodynamic support, prompt revascularization, monitoring
and management of blood glucose levels, antibiotic therapy for
infection and other disease-specific interventions. This also
included therapeutic hypothermia to be considered without
any delay immediately after return of spontaneous circulation
to a target of 33  1 °C core temperature [9]. Available meth-
ods for cooling included ice packs, intravenous infusion of cold
fluids, water-circulating cooling pads and precooled cooling
pads, surface and endovascular cooling according to local
protocols. Measurement of the core body temperature was site-
specific as were the details of the care pathway.
Data collection
The data for this study were obtained from the emergency
medical service and hospital patient care documentation using
standardised data abstraction forms. Electronic defibrillator
data were also analysed. Data were managed by a Data Coor-
dinating Center at the Medical College of Wisconsin (Milwau-
kee, WI, USA). Throughout the trial and the protocol
development for this cohort analysis access to the study data-
base was restricted to data coordinating centre staff [6]. The out
of hospital, emergency room, in hospital and discharge
assessments with regard to therapeutic hypothermia focused
on key data points within the ‘chain of survival’ [5,8,10].
Outcome measures
Survival to hospital discharge was chosen as outcome based on
its robustness, good coverage and clinical relevance over return
of spontaneous circulation or survival to hospital admission.
The outcome was dichotomised as being discharged from
hospital alive (yes vs. no).
Statistical analysis
Continuous data are presented as median and 25–75% quartiles;
categorical data as count and relative frequency. The exposure as
the initiation of therapeutic hypothermia at the organizational
level was categorised into out-of- plus in-hospital cooling (refer-
ence), in-hospital cooling alone and no cooling (Fig. 1). Demo-
graphic factors and factors related to cardiac arrest and treatment
according to the exposure levels were tabulated. To test the null
hypothesis of no difference between the exposure levels we used
a standard chi-squared test for categorical variables and a non-
parametric k-sample test on the equality of medians for contin-
uous variables. A nonparametric score test to test for a trend
across ordered categories was used. Logistic regressionwas then
undertaken in a stepwise fashion to account for the impact on
outcome of each significant difference and for the variable of
interest between the groups (cooling out of and/or in hospital
and no cooling on survival to discharge). To allow for the multi-
centre design of the study, we calculated the 95% confidence
intervals (CI) from robust standard errors based on clustering by
study site. Given the observational design and to adjust for
potential confounding, we introduced a-priori defined candidate
variables, which are known to be associated with the exposure
and outcome, but not being moderators as covariables into a
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multivariable logistic regression model. These variables were all
categorised and included sex, witnessed cardiac arrest, bystan-
der CPR, shockable initial rhythm, CIRC treatment allocation,
age, ‘no-flow’ time, ‘low-flow’ time and percutaneous coronary
intervention [10]. In case of missing data, we created ‘missing’
categories to include the information about missing data in our
analysis. Where applicable a category for missing values was
included. We tested for linear effects and first level interactions
using the likelihood ratio test. We used the Wald test to test the
null hypothesis of odds ratio = 1 in the models. Several sensi-
tivity analyses on the exposure classification were performed
and yielded virtually the same results. For datamanagement and
analyses MS EXCEL and STATA 11 for Mac (Stata Corp, College
Station, TX, USA) was used.
Results
Included in the CIRC trial were 4231 patients between 2009 and
2011. There were no important outcome differences between
LDB device and manual CPR groups [4].
Participants
Eligibility criteria for therapeutic hypothermia were met by
1812 individuals from within this cohort (Fig. 1). Overall
out-of- plus in-hospital cooled were 263 (15%) patients, cooled
only in hospital were 230 (13%) and not cooled were 357 (20%).
Descriptive data
Patient characteristics are presented in Table 1. Pertinent to
exposure status we observed relevant differences in witnessed
cardiac arrest, bystander CPR, shockable initial rhythm after
cardiac arrest, ‘low-flow’ time and return of spontaneous cir-
culation. The time from return of spontaneous circulation to
start of therapeutic hypothermia was significantly shorter for
patients cooled out of hospital compared to those receiving
therapeutic hypothermia only after hospital admission (19 [9–
29] vs. 97 min [60–181]; P < 0001). No significant differences in
temperature at admission and time to lowest temperature were
found (Table 1).
Outcome data
Outcome data on vital status at hospital discharge were
available for 1812 individuals included in this cohort. Dis-
charge data were missing for 12 patients. Among the 263
patients with out-of- plus in-hospital cooling were 98 (37%)
survivors, the 230 with in-hospital cooling alone 80 (35%) and
those with no cooling 68 (19%) (Table 2). Patients who had no
cooling had a 053 lower odds of survival (95% CI: 046–061,
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Figure 1 Patient flow chart. Selection of patients and distribution by location of initiation of therapeutic hypothermia.
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P < 0001), and those who had cooling only after hospital
admission had a 067 lower odds of survival (95% CI: 050–
089, P = 0006) compared to those who had cooling out of plus
in hospital (Table 3).
Discussion
Patients cooled to 33  1 °C for 24 h within this observational
cohort study showed an improvement in survival if therapeutic
Table 1 Characteristics of cardiac arrest study population according therapeutic hypothermia
Therapeutic hypothermia
Out- & In-hospital
n = 263
In-hospital
n = 230
No
n = 357
Age – median (IQR) 63 (53–74) 64 (52–75) 64 (55–76)
Female sex – n (%) 90 (34) 87 (38) 160 (45)
Public location – n (%) 48 (18) 67 (29) 124 (35)
Witnessed cardiac arrest – n (%)
Bystander 145 (55) 149 (65) 152 (43)
Emergency medical service 32 (12) 26 (7) 72 (20)
Bystander cardiopulmonary resuscitation – n (%) 120 (46) 124 (54) 161 (45)
Shockable rhythm- n (%) 122 (46) 112 (49) 110 (31)
Out-of-hospital return of spontaneous circulation – n (%) 263 (100) 210 (91) 308 (86)
Out-of-hospital rearrest – n (%) 70 (27) 64 (28) 104 (29)
Cardiopulmonary resuscitation at admission – n (%) 13 (5) 39 (17) 84 (24)
Rearrest at emergency department – n (%) 22 (8) 29 (13) 58 (16)
No-flow time* – n (%)
0–29 min 66 (25) 74 (32) 106 (30)
3–119 min 42 (16) 48 (21) 26 (7)
12+ min 27 (10) 21 (9) 30 (7)
No values available 128 (49) 87 (38) 195 (55)
Low-flow time† – n (%)
0–139 min 67 (25) 53 (23) 60 (17)
14–229 min 71 (27) 55 (24) 63 (18)
23+ min 62 (24) 52 (23) 81 (22)
No values available 63 (24) 70 (30) 153 (43)
Emergency medical service response time‡ (min) – median (IQR) 8 (6–11) 9 (5–12) 8 (0–11)
Emergency department admission temperature (°C) – median (IQR) 359 (348–364) 358 (351–364) 361 (353–368)
Time to therapeutic hypothermia (min) – median (IQR)£ 19 (9–29) 97 (60–181) –
Surface cooling – n (%) 162 (62) 151 (66) –
Lowest temperature (°C) – median (IQR) 327 (320–330) 326 (320–330) –
Percutaneous coronary intervention – n (%) 55 (21) 65 (28) 50 (14)
*Time from cardiac arrest until first attempted chest compression.
†Time from first attempted chest compression until first return of spontaneous circulation.
‡Time from emergency call until start of cardiopulmonary resuscitation by emergency medical service personal (= 0 min if cardiac arrest was witnessed by
emergency medical service).
£Time from restoration of spontaneous circulation until target temperature.
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hypothermia was applied out of hospital and continued in
hospital compared to those not cooled. Time to therapeutic
hypothermia was achieved more rapid if cooling was initiated
out of hospital. Moreover, individuals who were cooled only
after hospital admission had also better outcome than non-
cooled patients.
This study is a cohort study investigating the effect of
therapeutic hypothermia on survival from patients initially
enrolled into the randomised CIRC trial [4] with it is major
limitation not being a randomised prospective trial. In our
opinion even so the data seems to be worth being reported
and not hold back from the therapeutic hypothermia resusci-
tation research interested community, even with risk of
selection bias that this study is associated. The primary find-
ing is that there is an association between out-of-hospital or in-
hospital delivery of induced hypothermia with improved
survival confirming at least some previous in-hospital cooling
trials [11,12]. The initiation and/or continuation of therapeutic
hypothermia occurred at the discretion of treating personnel
and were likely influenced by perceptions of patients’ likeli-
hood of survival and benefitting from the treatment. Resusci-
tation guidelines in place at the time of the study and the
CIRC study protocol directed that all patients receive thera-
peutic hypothermia without any delay immediately after
return of spontaneous circulation. This made the group with
therapeutic hypothermia initiated out of hospital and contin-
ued in hospital having improved out-of-hospital return of
sustained circulation, less ongoing CPR at admission and
rearrest at the emergency department. Making it to the hos-
pital with restoration of spontaneous circulation after cardiac
arrest in itself is a strong criterion for primary resuscitation
success. The groups only cooled or not after hospital admis-
sion showed no major cardiac arrest and resuscitation related
differences and thus seemed to have quite equal basic condi-
tions for proofing that cooling might be effective in improving
outcome. The higher rearrest rates (16% vs. 8%) of the group
not cooled may reflect the negligible prognoses of these
patients and thus no consideration for therapeutic hypother-
mia. However, this could have also demonstrated early
Table 2 Unadjusted associations of initiation of therapeutic
hypothermia effects on survival-to-hospital discharge
Survival to
hospital
discharge
n/N (%)
Unadjusted
odds ratio for
survival-to-hospital-
discharge (95% CI)* P-value
Therapeutic hypothermia
Out- & In hospital 98/263 (37) Reference
In hospital 80/230 (35) 090 (055–146) 066
No 68/357 (19) 041 (027–064) < 0001
*Based on cluster robust standard errors to allow for multicentre design.
Table 3 Adjusted estimates of factors for survival-to-hospital
discharge from a multivariable logistic regression model
Adjusted odds ratio
for survival-to-hospital
discharge (95% CI)* P-value
Therapeutic hypothermia
Out- & In hospital Reference
In hospital 067 (050–089) 0006
No 053 (046–061) < 0001
Sex (female vs. male) 110 (089–137) 036
Age (by quintile) 084 (069–101) 007
Witnessed cardiac arrest
Not witnessed Reference
By bystander 262 (212–324) < 0001
By emergency
medical service
456 (282–736) < 0001
No flow time†
0–29 min Reference
3–119 min 075 (044–128) 029
12+ min 098 (068–140) 090
No values available 095 (061–149) 084
Low flow time‡
0–139 min Reference
14–229 min 034 (023–050) < 0001
23+ min 017 (010–029) < 0001
No values available 020 (011–034) < 0001
Shockable initial
rhythm (yes vs. no)
296 (210–418) < 0001
Random allocation
(Circulation Improving
Resuscitation Care Trial)
096 (079–117) 070
Bystander
cardiopulmonary
resuscitation (yes vs. no)
238 (160–352) < 0001
Percutaneous
coronary intervention
372 (182–761) < 0001
*Based on cluster robust standard errors to allow for multicentre design.
†Time from cardiac arrest until first attempted cardiopulmonary resuscitation.
‡Time from first attempted cardiopulmonary resuscitation until first return of
spontaneous circulation.
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benefits of cooling with rearrest rates of only 8% in the out-of-
plus in-hospital cooling group. These low rearrest rates in out-
of- vs. in-hospital cooled patients in addition contradict the
postulated potential deleterious effects of cold intravenous
fluid administration out of hospital, but might also be
explained by the high rates of out of hospital applied surface
cooling methods (Table 1) [13,14]. Outcome from out-of-hos-
pital cardiac arrest is about much more than just survival –
good health related quality of life or functional capacity of
survivors is vital. Unfortunately, neurologic outcomes were
missing for 28% of the cases in the CIRC trial. This was
mainly due to lack of informed consent, which however
occurred equally in all groups [4]. Due to the very small
numbers of conscious survivors in each group this results are
not reported here. Estimates about rates of withdrawal of life
sustaining treatment allow the assumption, that there might
have been no differences between groups. Therefore, it was
unlikely to have introduced any bias into our results. The
magnitude of missing data is somewhat high, but did not
seem to differ between treatment groups and did not impact
on the robustness of our results.
A systematic review of ten observational studies described
lower in-hospital mortality among patients treated with thera-
peutic hypothermia (33  1 °C) [11,12,15]. These and our
results challenge a study comparing cooling to 33 or 36 °C [2]
and three cohort studies including a total of 1034 patients [16–
18]. Testori et al. [17] have shown a benefit in mortality at
6 months similar to our findings at discharge from hospital.
There is a lack of information available comparing different
durations and time of initiation of targeted temperature man-
agement [19,20]. Seven trials with a total of 2237 patients
demonstrate no overall difference in mortality for patients
treated with out-of-hospital cooling compared to those who did
not receive out-of-hospital cooling [3,21–24]. These studies
provided additional insight into the relationship between ear-
lier cooling and outcomes, although this is complicated by
issues related to variation in the methods of cooling and further
in-hospital targeted temperature management. Further studies
found that patients who were cooled to 33 °C more quickly had
a better outcome [25–28].
There is an urgent need to further elucidate the optimal
components of targeted temperature management. Many dif-
ferent sedation, analgesia and relaxation protocols were used
not only in general clinical practice but also in our cohort study.
Unfortunately, we were not able to get detailed information
regarding postresuscitation critical care and therefore are not
able to report on symptoms and clinical details such as shiv-
ering during cooling [29].
Due to the difficulties in carrying out randomised clinical
trials on using therapeutic hypothermia throughout the chain
of survival after cardiac arrest, observational studies are
becoming more popular to investigate the relationship between
cooling and outcomes [27,30–35]. In our retrospective cohort
study, we defined the selected group of people with or without
therapeutic hypothermia from the CIRC trial who were
followed up to determine incidence of mortality from
out-of-hospital cardiac arrest of presumed cardiac origin. Even
with our limited control about the cooling procedures and
something possible fundamentally different about those who
were cooled compared to those not cooled, which could also be
related to survival (i.e., they rearrest and never came back, or
they were somehow deemed unlikely to survive, etc.), we think,
that we are able to draw conclusion based on collected cooling-
related data (i.e., target temperature of 33  1 °C for 24 h) with
no loss to follow-up for mortality data in the CIRC trial.
Nonetheless, this retrospective analysis of the CIRC trial had
some limitations. It was not feasible to blind patients or pro-
viders about whether hypothermia was initiated and main-
tained; however, the outcome assessors in relation to
therapeutic hypothermia were blinded. Secondly, it was
impossible to standardise hospital-based postresuscitation care,
and we were not able to control hospital treatment. Therefore,
adjusting for percutaneous coronary intervention as post-
exposure factor which could correlate with outcome might be a
limitation. Patients were frequently discharged alive before
consent for ongoing participating could be obtained, limiting
the amount of modified Rankin Scale data we were allowed to
collect.
More people can survive sudden cardiac arrest when a par-
ticular sequence of events occurs as rapidly as possible. The
descriptive ‘chain of survival’ communicates this understand-
ing in a useful way. While separate specialised programmes are
necessary to develop strength in each link, all of the links must
be connected. Weakness in any link lessens the chance of sur-
vival and condemns the efforts of an emergency medical ser-
vices system to poor results. This holds especially true for
therapeutic hypothermia, where standard principles of system
management are often missing. It emphasises that there are no
easy, single-step, cooling approaches to improve survival from
cardiac arrest [2,3,5,28,36,37].
Conclusion
The results of our observational study suggest that there is an
association between out-of-hospital or in-hospital delivery of
induced hypothermia with improved survival after cardiac
arrest.
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